Cetrorelix - Tulane University
Alternative Names: Cetrorelix acetate; Cetrorelix pamoate; Cetrotide; NS 75A; NS 75B; SB 075; SB 75Latest Information Update: 05 Nov 2023
At a glance
- Originator Tulane University
- Developer AEterna Zentaris Inc; Merck Serono; Shionogi
- Class Infertility therapies; Peptides
- Mechanism of Action Gonadotropin releasing hormone inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- Marketed Female infertility
- Discontinued Benign prostatic hyperplasia; Breast cancer; Endometriosis; Ovarian cancer; Prostate cancer; Uterine leiomyoma